Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Viewray Inc (VRAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Viewray Inc Latest News and Headlines for [[ item.sessionDateDisplayLong ]]
World's First MRIdian Center Treats 1,000th Patient with MRI-Guided Radiation Therapy

ViewRay, Inc. (Nasdaq: VRAY) announced today that the clinical team at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has treated its 1,000th...

VRAY : 8.75 (-1.35%)
ViewRay® to Present at the Jefferies 2019 Global Healthcare Conference

ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in the Jefferies 2019 Global Healthcare Conference in New York, New York. Scott Drake, President and CEO, will participate...

VRAY : 8.75 (-1.35%)
Biotech Stocks: Global Revenues for Ophthalmology Market Projected to Reach $26 Billion by 2022

As the baby boomer generation ages, there is an increased need no a demand by these aging patients to avert vision and blindness problems that come with aging. An industry report GBI Research stated that...

PTCT : 40.01 (-4.05%)
GHSI : 1.60 (-0.93%)
RMTI : 4.18 (-1.42%)
BSGM : 7.91 (+5.89%)
VRAY : 8.75 (-1.35%)
Biotech Stocks - U.S. Holds On With Largest Medical Device Market Estimated at over $150 Billion

Medical device and technology development is an area where the U.S. companies are at the forefront. According to a SelectUSA.gov publication, the United States remains the largest medical device market...

CELG : 96.51 (+0.07%)
MHMNF : 54.5000 (unch)
IMGN : 1.98 (-9.17%)
VRAY : 8.75 (-1.35%)
ALXN : 117.93 (+0.59%)
ViewRay (VRAY) Reports Q1 Loss, Lags Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of -54.55% and -3.30%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

VRAY : 8.75 (-1.35%)
ViewRay Reports First Quarter 2019 Results

ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2019.

VRAY : 8.75 (-1.35%)
ViewRay's MRIdian to be Featured at Leading European Radiation Oncology Meeting

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the European Society for Radiotherapy and Oncology...

VRAY : 8.75 (-1.35%)
Global Cellulite Treatments Market Could Exceed $1.4 Billion by 2026

The global cellulite market and its largest segment, the non-invasive treatment sector, are both expected to grow at a healthy rate. A recent industry report on the entire cellulite market (from Transparency...

HSM.TO : 3.88 (-3.96%)
CTLT : 49.69 (-1.25%)
HSDT : 2.92 (-2.67%)
VRAY : 8.75 (-1.35%)
MDT : 97.50 (unch)
SOLY : 14.30 (-9.21%)
ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company has partnered with Minogue Medical Inc., a leading Canadian distributor of surgical devices, operating room disposables, hospital equipment,...

VRAY : 8.75 (-1.35%)
ViewRay Partners with Largest Independent Distributor in Australia and New Zealand to Bring Benefits of MRI-Guided Radiation Therapy to the Region

ViewRay, Inc. (Nasdaq: VRAY) and Device Technologies Australia Pty Ltd (Device Technologies) announced today a partnership in which Device Technologies, the largest independent distributor in Australasia,...

VRAY : 8.75 (-1.35%)
Report: Developing Opportunities within Navient, Avis Budget Group, ViewRay, Apollo Commercial Real Estate Finance, West Pharmaceutical Services, and Myomo -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Navient Corporation (NASDAQ:NAVI),...

NAVI : 13.33 (-0.22%)
MYO : 0.77 (+4.05%)
CAR : 33.24 (+1.78%)
ARI : 18.79 (+0.27%)
WST : 120.68 (-1.00%)
VRAY : 8.75 (-1.35%)
ViewRay Announces Conference Call and Webcast of First Quarter 2019 Financial Results to be Held After Market on May 2, 2019

ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2019 financial results.

VRAY : 8.75 (-1.35%)
ViewRay Announces Publication of Retrospective Study on MR-guided Radiation Treatment for Locally Advanced Pancreatic Cancer

ViewRay, Inc. (Nasdaq: VRAY) announced today the publication of a retrospective analysis of outcomes for the stereotactic treatment of locally advanced pancreatic cancer using precise, high-dose MRI-guided...

VRAY : 8.75 (-1.35%)
ViewRay (VRAY) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, ViewRay (VRAY) closed at $7.72, marking a -0.13% move from the previous day.

VRAY : 8.75 (-1.35%)
ViewRay (VRAY) Stock Sinks As Market Gains: What You Should Know

ViewRay (VRAY) closed at $7.39 in the latest trading session, marking a -0.4% move from the prior day.

VRAY : 8.75 (-1.35%)
ViewRay (VRAY) Stock Moves -1.59%: What You Should Know

In the latest trading session, ViewRay (VRAY) closed at $8.37, marking a -1.59% move from the previous day.

VRAY : 8.75 (-1.35%)
Fluidigm (FLDM) in Focus: Stock Moves 8% Higher

Fluidigm (FLDM) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

VRAY : 8.75 (-1.35%)
FLDM : 12.25 (+0.25%)
ViewRay Reports Fourth Quarter and Full Year 2018 Results

ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2018.

VRAY : 8.75 (-1.35%)
ViewRay, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 14, 2019 / ViewRay, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 14, 2019, 2018 at 4:30 PM Eastern...

VRAY : 8.75 (-1.35%)
Why Regulations for Clinical Trials are Resulting in Streamlined Approval Process

Recent upgrades in international and domestic regulations regarding clinical trials, are both designed to protect patients, but also to upgrade the 'new normal' procedures in clinical trial quality and...

SANM : 28.05 (-2.81%)
CVRS : 2.74 (-2.84%)
TEVA : 8.24 (-4.30%)
VRAY : 8.75 (-1.35%)
PAVM : 1.15 (+1.77%)
SOLY : 14.30 (-9.21%)

Van Meerten Stock Picks

Columbia Fixed Income ETF
My Stock Pick of the Day is an ETF - Columbia Diversified Fixed Income Allocation ETF (DIAL).
DIAL unch
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar